Transcription elongation factor ELL2 drives ig secretory-specific mRNA production and the unfolded protein response

Journal of Immunology

Volumn 193, Issue 9, 2014, Pages 4663-4674

  Park, Kyung Soo ^a   Bayles, Ian ^a   Szlachta McGinn, Alec ^a   Paul, Joshua ^a   Boiko, Julie ^a   Santos, Patricia ^a   Liu, June ^a   Wang, Zhou ^a   Borghesi, Lisa ^a   Milcarek, Christine ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; B CELL MATURATION ANTIGEN; CD19 ANTIGEN; CD45 ANTIGEN; CELL PROTEIN; COMPLEMENTARY DNA; CYCLIN B2; GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN IRE1ALPHA; PROTEIN OCAB; SYNDECAN 1; TRANSCRIPTION ELONGATION FACTOR; TRANSCRIPTION ELONGATION FACTOR ELL2; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; ELL2 PROTEIN, MOUSE; IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; ELL2 GENE; ENDOPLASMIC RETICULUM; EX VIVO STUDY; EXON; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOGLOBULIN PRODUCTION; KNOCKOUT MOUSE; LONG TERM SURVIVAL; LYMPHOCYTE COUNT; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PLASMA CELL; PROMOTER REGION; PROTEIN DEFICIENCY; PROTEIN PHOSPHORYLATION; RNA SPLICING; SPLEEN; UNFOLDED PROTEIN RESPONSE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DEFICIENCY; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE ORDER; GENE TARGETING; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PHENOTYPE; ULTRASTRUCTURE;

ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; GENE DELETION; GENE EXPRESSION; GENE ORDER; GENE TARGETING; GENETIC LOCI; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; MICE; MICE, KNOCKOUT; PHENOTYPE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ELONGATION FACTORS; UNFOLDED PROTEIN RESPONSE;

EID: 84908136678     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401608     Document Type: Article

References (49)

1. Martincic, K., S. A. Alkan, A. Cheatle, L. Borghesi, and C. Milcarek. 2009. Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing. Nat. Immunol. 10: 1102-1109.
2. Shaffer, A. L., M. Shapiro-Shelef, N. N. Iwakoshi, A. H. Lee, S. B. Qian, H. Zhao, X. Yu, L. Yang, B. K. Tan, A. Rosenwald, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93.
3. Ochiai, K., M. Maienschein-Cline, G. Simonetti, J. Chen, R. Rosenthal, R. Brink, A. S. Chong, U. Klein, A. R. Dinner, H. Singh, and R. Sciammas. 2013. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 38: 918-929.
4. O'Connor, B. P., V. S. Raman, L. D. Erickson, W. J. Cook, L. K. Weaver, C. Ahonen, L.-L. Lin, G. T. Mantchev, R. J. Bram, and R. J. Noelle. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199: 91-98.
5. Nutt, S. L., N. Taubenheim, J. Hasbold, L. M. Corcoran, and P. D. Hodgkin. 2011. The genetic network controlling plasma cell differentiation. Semin. Immunol. 23: 341-349.
6. Shaffer, A. L., N. C. T. Emre, L. Lamy, V. N. Ngo, G. Wright, W. Xiao, J. Powell, S. Dave, X. Yu, H. Zhao, et al. 2008. IRF4 addiction in multiple myeloma. Nature 454: 226-231.
7. Sciammas, R., A. L. Shaffer, J. H. Schatz, H. Zhao, L. M. Staudt, and H. Singh. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25: 225-236.
8. Shell, S. A., K. Martincic, J. Tran, and C. Milcarek. 2007. Increased phos-phorylation of the carboxyl-terminal domain of RNA polymerase II and loading of polyadenylation and cotranscriptional factors contribute to regulation of the ig heavy chain mRNA in plasma cells. J. Immunol. 179: 7663-7673.
9. Milcarek, C., M. Albring, C. Langer, and K. S. Park. 2011. The eleven-nineteen lysine-rich leukemia gene (ELL2) influences the histone H3 protein modifications accompanying the shift to secretory immunoglobulin heavy chain mRNA production. J. Biol. Chem. 286: 33795-33803.
10. Smith, E., C. Lin, and A. Shilatifard. 2011. The super elongation complex (SEC) and MLL in development and disease. Genes Dev. 25: 661-672.
11. Luo, Z., C. Lin, and A. Shilatifard. 2012. The super elongation complex (SEC) family in transcriptional control. Nat. Rev. Mol. Cell Biol. 13: 543-547.
12. Benson, M. J., T. Aijö, X. Chang, J. Gagnon, U. J. Pape, V. Anantharaman, L. Aravind, J.-P. Pursiheimo, S. Oberdoerffer, X. S. Liu, et al. 2012. Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells. Proc. Natl. Acad. Sci. USA 109: 16252-16257.
13. He, N., M. Liu, J. Hsu, Y. Xue, S. Chou, A. Burlingame, N. J. Krogan, T. Alber, and Q. Zhou. 2010. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol. Cell 38: 428-438.
14. Yang, Q., B. Esplin, and L. Borghesi. 2011. E47 regulates hematopoietic stem cell proliferation and energetics but not myeloid lineage restriction. Blood 117: 3529-3538.
15. Borghesi, L., J. Aites, S. Nelson, P. Lefterov, P. James, and R. Gerstein. 2005. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J. Exp. Med. 202: 1669-1677.
16. Santos, P. M., Y. Ding, and L. Borghesi. 2014. Cell-intrinsic in vivo requirement for the E47-p21 pathway in long-term hematopoietic stem cells. J. Immunol. 192: 160-168.
17. Winkelmann, R., L. Sandrock, M. Porstner, E. Roth, M. Mathews, E. Hobeika, M. Reth, M. L. Kahn, W. Schuh, and H.-M. Jäck. 2011. B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2. Proc. Natl. Acad. Sci. USA 108: 710-715.
18. Martin, R. M., J. L. Brady, and A. M. Lew. 1998. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212: 187-192.
19. Shapiro-Shelef, M., K.-I. Lin, L. J. McHeyzer-Williams, J. Liao, M. G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19: 607-620.
20. Krause, K., M. Wasner, W. Reinhard, U. Haugwitz, C. L. Dohna, J. Mössner, and K. Engeland. 2000. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res. 28: 4410-4418.
21. Salsi, V., G. Caretti, M. Wasner, W. Reinhard, U. Haugwitz, K. Engeland, and R. Mantovani. 2003. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J. Biol. Chem. 278: 6642-6650.
22. Bruce, S. R., R. W. C. Dingle, and M. L. Peterson. 2003. B-cell and plasma-cell splicing differences: a potential role in regulated immunoglobulin RNA processing. RNA 9: 1264-1273.
23. Screaton, G. R., J. F. Cáceres, A. Mayeda, M. V. Bell, M. Plebanski, D. G. Jackson, J. I. Bell, and A. R. Krainer. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14: 4336-4349.
24. Mitani, K., T. Yamagata, C. Iida, H. Oda, K. Maki, M. Ichikawa, T. Asai, H. Honda, M. Kurokawa, and H. Hirai. 2000. Nonredundant roles of the elongation factor MEN in postimplantation development. Biochem. Biophys. Res. Commun. 279: 563-567.
25. Rickert, R. C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cremediated mutagenesis in mice. Nucleic Acids Res. 25: 1317-1318.
26. Genovese, C., S. Harrold, and C. Milcarek. 1991. Differential mRNA stabilities affect mRNA levels in mutant mouse myeloma cells. Somat. Cell Mol. Genet. 17: 69-81.
27. Zabel, F., D. Mohanan, J. Bessa, A. Link, A. Fettelschoss, P. Saudan, T. M. Kündig, and M. F. Bachmann. 2014. Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies. J. Immunol. 192: 5499-5508.
28. Genovese, C., and C. Milcarek. 1990. Increased half-life of mu Ig mRNA during mouse B-cell development increases abundancy. Mol. Immunol. 17: 69-81.
29. Shen, Y., and L. M. Hendershot. 2007. Identification of ERdj3 and OBF-1/BOB-1/OCA-B as direct targets of XBP-1 during plasma cell differentiation. J. Immunol. 179: 2969-2978.
30. Taubenheim, N., D. M. Tarlinton, S. Crawford, L. M. Corcoran, P. D. Hodgkin, and S. L. Nutt. 2012. High rate of antibody secretion is not integral to plasma cell differentiation as revealed by XBP-1 deficiency. J. Immunol. 189: 3328-3338.
31. Jackman, M., M. Firth, and J. Pines. 1995. Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J. 14: 1646-1654.
32. Calfon, M., H. Zeng, F. Urano, J. H. Till, S. R. Hubbard, H. P. Harding, S. G. Clark, and D. Ron. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415: 92-96.
33. Gass, J. N., N. M. Gifford, and J. W. Brewer. 2002. Activation of an unfolded protein response during differentiation of antibody-secreting B cells. J. Biol. Chem. 277: 49047-49054.
34. Tirasophon, W., K. Lee, B. Callaghan, A. Welihinda, and R. J. Kaufman. 2000. The endoribonuclease activity of mammalian IRE1 autoregulates its mRNA and is required for the unfolded protein response. Genes Dev. 14: 2725-2736.
35. Lee, K., W. Tirasophon, X. Shen, M. Michalak, R. Prywes, T. Okada, H. Yoshida, K. Mori, and R. J. Kaufman. 2002. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 16: 452-466.
36. Davenport, E. L., H. E. Moore, A. S. Dunlop, S. Y. Sharp, P. Workman, G. J. Morgan, and F. E. Davies. 2007. Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells. Blood 110: 2641-2649.
37. Pincus, D., M. W. Chevalier, T. Aragón, E. van Anken, S. E. Vidal, H. El-Samad, and P. Walter. 2010. BiP binding to the ER-stress sensor Ire1 tunes the homeostatic behavior of the unfolded protein response. PLoS Biol. 8: e1000415.
38. Shilatifard, A. 1998. Factors regulating the transcriptional elongation activity of RNA polymerase II. FASEB J. 12: 1437-1446.
39. Yoshida, H., T. Okada, K. Haze, H. Yanagi, T. Yura, M. Negishi, and K. Mori. 2000. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol. Cell. Biol. 20: 6755-6767.
40. Takayanagi, S., R. Fukuda, Y. Takeuchi, S. Tsukada, and K. Yoshida. 2013. Gene regulatory network of unfolded protein response genes in endoplasmic reticulum stress. Cell Stress Chaperones 18: 11-23.
41. Filippov, V., E. L. Schmidt, M. Filippova, and P. J. Duerksen-Hughes. 2008. Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes. Gene 420: 34-41.
42. van Anken, E., E. P. Romijn, C. Maggioni, A. Mezghrani, R. Sitia, I. Braakman, and A. J. R. Heck. 2003. Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion. Immunity 18: 243-253.
43. Kumazaki, K., B. Tirosh, R. Maehr, M. Boes, T. Honjo, and H. L. Ploegh. 2007. AID-/-mus-/- mice are agammaglobulinemic and fail to maintain B220-CD138+ plasma cells. J. Immunol. 178: 2192-2203.
44. Ma, Y., Y. Shimizu, M. J. Mann, Y. Jin, and L. M. Hendershot. 2010. Plasma cell differentiation initiates a limited ER stress response by specifically suppressing the PERK-dependent branch of the unfolded protein response. Cell Stress Chaperones 15: 281-293.
45. Gass, J. N., H.-Y. Jiang, R. C. Wek, and J. W. Brewer. 2008. The unfolded protein response of B-lymphocytes: PERK-independent development of antibody-secreting cells. Mol. Immunol. 45: 1035-1043.
46. Reimold, A. M., N. N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E. M. Gravallese, D. Friend, M. J. Grusby, F. Alt, and L. H. Glimcher. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412: 300-307.
47. Tirosh, B., N. N. Iwakoshi, L. H. Glimcher, and H. L. Ploegh. 2005. XBP-1 specifically promotes IgM synthesis and secretion, but is dispensable for degradation of glycoproteins in primary B cells. J. Exp. Med. 202: 505-516.
48. Aragon, I. V., R. A. Barrington, S. Jackowski, K. Mori, and J. W. Brewer. 2012. The specialized unfolded protein response of B lymphocytes: ATF6α-independent development of antibody-secreting B cells. Mol. Immunol. 51: 347-355.
49. Benhamron, S., R. Hadar, T. Iwawaky, J.-S. So, A.-H. Lee, and B. Tirosh. 2014. Regulated IRE1-dependent decay participates in curtailing immunoglobulin secretion from plasma cells. Eur. J. Immunol. 44: 867-876.